Rising costs are hitting every corner of the global economy. Businesses large and small are struggling to manage these pressures, although some are better placed than others to pass on costs to consumers.
Reckitt Benckiser Group (LSE: RKT) seems to be one of those organisations that can pass on costs. The FTSE 100 manufacturer of Dettol, Nurofen and Durex is shrugging off inflation in its supply chain.
In the first quarter of 2022, like-for-like sales increased by 5.6% overall with price rises contributing 5.3% and volume adding another 0.3%. More importantly, management believes sales growth for the year as a whole will be at the top of its 1% to 4% target range, and Reckitt will be able to maintain its adjusted operating margins as it hikes prices to offset rising input costs.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Margin performance shows Reckitt’s strengths
It looks as if the buyers of Reckitt’s health and cleaning brands have not been put off by higher prices.
Indeed, they seem willing to pay more for its branded products, although as the cost of living squeeze continues, this might not last. There is plenty of evidence showing that consumers tend to trade down to supermarket own-brand products and other cheaper alternatives when disposable income comes under pressure. There’s no guarantee this trend will play out, but it’s something investors need to keep in mind. If real incomes keep falling, and the firm keeps raising prices, volume growth could disappear.
Still, Reckitt’s outlook is more upbeat than that of its FTSE 100 peer, Unilever (LSE: ULVR). Both companies are facing the same headwinds. However, Unilever expects its operating profit margin to fall to the lower end of its previously forecast 16% to 17% range for 2022 as it deals with supply chain issues. I’ve taken a closer look at Unilever’s first quarter performance and what it means for investors here.
Unilever's forecast stands in contrast with Reckitt’s outlook. One of the reasons Unilever is feeling the heat is its presence in the food and beverage categories, where ingredient inflation is running much hotter.
A key ingredient of many of the company’s products is palm oil, which has doubled in price over the past year. And there could be further pain ahead for Unilever as the world’s largest buyer of palm oil.
Around 90% of the world’s palm oil comes from Indonesia and Malaysia, but Indonesia has just announced an export ban. This ban has the potential to exacerbate global supply issues and push prices up further.
Reckitt is positioning itself for growth in a tough market
Considering Unilever’s challenges, Reckitt looks to be the better buy of the two, although I own both in my portfolio.
To help boost growth, the FTSE 100 company is managing its portfolio for “high growth”, which involves divesting brands that are not living up to expectations. To that end, Reckitt recently divested the Dermicool and E45 brands for £240m.
There are also rumours that Reckitt is looking to offload the remainder of its baby formula business. This has been a thorn in its company’s side since it agreed to acquire Mead Johnson in 2017. The $16.6bn deal was supposed to open up a new growth market for the group, but it has failed to live up to expectations. New regulations in China favouring local rivals also damaged its growth prospects.
Reckitt has written the value of the business down by $10bn and sold the China arm for $2.2bn. The remainder of the baby formula business could be worth $7bn to $10bn according to analysts. A deal would draw a line under this messy chapter and allow management to re-focus their efforts on the rest of the business.
According to FactSet, analysts believe the company will report earnings per share of 298p in 2022 and 323p in 2023, putting the stock on a 2023 price/earnings (p/e) multiple of 19.3, roughly inline with peer Unilever. Considering Reckitt’s defensive qualities, sales growth and margin performance in a tough environment, I think that undervalues the business. It also offers a dividend yield of 2.8%.
As uncertainty stalks the global economy, Reckitt could provide a safe haven for investors.
Disclosure: Rupert Hargreaves owns shares in Reckitt and Unilever.
Rupert is the Deputy Digital Editor of MoneyWeek. He has been an active investor since leaving school and has always been fascinated by the world of business and investing.
His style has been heavily influenced by US investors Warren Buffett and Philip Carret. He is always looking for high-quality growth opportunities trading at a reasonable price, preferring cash generative businesses with strong balance sheets over blue-sky growth stocks.
Rupert was a freelance financial journalist for 10 years before moving to MoneyWeek, writing for several UK and international publications aimed at a range of readers, from the first timer to experienced high net wealth individuals and fund managers. During this time he had developed a deep understanding of the financial markets and the factors that influence them.
He has written for the Motley Fool, Gurufocus and ValueWalk among others. Rupert has also founded and managed several businesses, including New York-based hedge fund newsletter, Hidden Value Stocks, written over 20 ebooks and appeared as an expert commentator on the BBC World Service.
He has achieved the CFA UK Certificate in Investment Management, Chartered Institute for Securities & Investment Investment Advice Diploma and Chartered Institute for Securities & Investment Private Client Investment Advice & Management (PCIAM) qualification.
M&S shares shift from frumpy to fabulous as pre-tax profits are up by 56%
M&S is performing strongly and has announced it will pay a dividend for the first time since the pandemic.
By Dr Matthew Partridge Published
The rise and fall of Sam Bankman-Fried – the “boy wonder of crypto”
Why the fate of Sam Bankman-Fried reminds us to be wary of digital tokens and unregulated financial intermediaries.
By Jane Lewis Published
Halifax: House price slump continues as prices slide for the sixth consecutive month
UK house prices fell again in September as buyers returned, but the slowdown was not as fast as anticipated, latest Halifax data shows. Where are house prices falling the most?
By Kalpana Fitzpatrick Published
Rents hit a record high - but is the opportunity for buy-to-let investors still strong?
UK rent prices have hit a record high with the average hitting over £1,200 a month says Rightmove. Are there still opportunities in buy-to-let?
By Marc Shoffman Published
Pension savers turn to gold investments
Investors are racing to buy gold to protect their pensions from a stock market correction and high inflation, experts say
By Ruth Emery Published
Where to find the best returns from student accommodation
Student accommodation can be a lucrative investment if you know where to look.
By Marc Shoffman Published
Best investing apps
We round up the best investing apps. Looking for an easy-to-use app to help you start investing, keep track of your portfolio or make trades on the go?
By Ruth Emery Last updated
The top funds to invest in - November 2023
Tips Investors are focused on income strategies and FTSE heavyweights. We look at what investors have been adding to their portfolios in the last month
By Vaishali Varu Last updated
The world’s best bargain stocks
Searching for bargain stocks with Alec Cutler of the Orbis Global Balanced Fund, who tells Andrew Van Sickle which sectors are being overlooked.
By Andrew Van Sickle Published
Revealed: the cheapest cities to own a home in Britain
New research reveals the cheapest cities to own a home, taking account of mortgage payments, utility bills and council tax
By Ruth Emery Published